Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Abou Family ResidenceXTAE:ABOU 25 Earnings Yield (Joel Greenblatt) % is 3.60% as of Jun. 2026. GuruFocus rates XTAE:ABOU with a GF Score™ of 25/100. The stock has 1 warning sign investors should review. Among 849 Medical Devices & Instruments companies, Abou Family Residence ranks worse than 55.36% on this metric.
Abou Family Residence's Enterprise Value for the quarter that ended in Jun. 2026 was ₪948.31 Mil.
Abou Family Residence's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 was ₪34.09 Mil. Abou Family Residence's Earnings Yield (Joel Greenblatt) for the quarter that ended in Jun. 2026 was 3.60%.
The historical rank and industry rank for Abou Family Residence's Earnings Yield (Joel Greenblatt) % or its related term are showing as below:
XTAE:ABOU's Earnings Yield (Joel Greenblatt) % is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 1.29 * Ranked among companies with meaningful Earnings Yield (Joel Greenblatt) % only.
Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.
A better indicator of the attractiveness of an investment which takes growth into account is the Forward Rate of Return (Yacktman) %. Abou Family Residence's Forward Rate of Return (Yacktman) % for the quarter that ended in Jun. 2026 was %. The Forward Rate of Return uses the normalized Free Cash Flow of the past five years, and considers growth. The forward rate of return can be thought of as the return that investors buying the stock today can expect from it in the future.
Abou Family Residence (XTAE:ABOU) Earnings Yield (Joel Greenblatt) % Explanation
Joel Greenblatt defines the earnings yield using the above equation because it more accurately reflects the company's profitability relative to its stock price. Items like interest payment and tax etc. are not directly related to the company's operational profitability.
Enterprise Value instead of market cap (share price) is used in the calculation because it is the real price stock and bond investors together pay for the company.
Be Aware
Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.
Abou Family Residence Earnings Yield (Joel Greenblatt) % Related Terms
Abou Family Residence Earnings Yield (Joel Greenblatt) % Historical Data
* Premium members only.
The historical data trend for Abou Family Residence's Earnings Yield (Joel Greenblatt) % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Abou Family Residence Earnings Yield (Joel Greenblatt) % Chart
For the Medical Devices subindustry, Abou Family Residence's Earnings Yield (Joel Greenblatt) %, along with its competitors' market caps and Earnings Yield (Joel Greenblatt) % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Abou Family Residence Earnings Yield (Joel Greenblatt) % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Abou Family Residence's Earnings Yield (Joel Greenblatt) % distribution charts can be found below:
* The bar in red indicates where Abou Family Residence's Earnings Yield (Joel Greenblatt) % falls into.
Abou Family Residence Earnings Yield (Joel Greenblatt) % Calculation
In his book, The Little That Beat the Market, hedge fund manager Joel Greenblatt defines Earnings Yield as operating income divided by enterprise value.
Abou Family Residences Earnings Yield (Joel Greenblatt) for the fiscal year that ended in Dec. 2025 is calculated as
For company reported semi-annually or annually, GuruFocus only calculate annual data for Earnings Yield (Joel Greenblatt) and apply the annual figure to corresponding quarter.
What does a Earnings Yield (Joel Greenblatt) % of 3.60% mean?
Abou Family Residence (XTAE:ABOU) has a Earnings Yield (Joel Greenblatt) % of 3.60% as of Jun. 2026. Joel Greenblatt's earnings yield equals the ratio of earnings before interest and taxes to enterprise value. View historical data on Abou Family Residence and its competitors. According to the industry distribution chart, Abou Family Residence ranks #470 out of 849 companies in the Medical Devices & Instruments industry, placing it in the top 55.4%.
Is Abou Family Residence's Earnings Yield (Joel Greenblatt) % too high?
Abou Family Residence's current Earnings Yield (Joel Greenblatt) % is 3.60%. The Medical Devices & Instruments industry median Earnings Yield (Joel Greenblatt) % is 1.29. Abou Family Residence's value of 3.60% is 179.1% above this industry median. Based on the distribution chart, Abou Family Residence ranks #470 out of 849 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Abou Family Residence has a GF Score™ of 25/100, reflecting its overall financial health beyond just this single metric.
How does Abou Family Residence's Earnings Yield (Joel Greenblatt) % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Abou Family Residence ranks #470 out of 849 companies for Earnings Yield (Joel Greenblatt) %. This places Abou Family Residence in the lower half of its industry. The industry median Earnings Yield (Joel Greenblatt) % is 1.29. Abou Family Residence's value of 3.60% is 179.1% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Earnings Yield (Joel Greenblatt) % for a Medical Devices & Instruments company?
The median Earnings Yield (Joel Greenblatt) % among Medical Devices & Instruments companies is 1.29, based on 849 companies in the industry. Companies in the top quartile (top 25%) have a Earnings Yield (Joel Greenblatt) % significantly above this median, while those in the bottom quartile fall well below. However, Earnings Yield (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Abou Family Residence's current Earnings Yield (Joel Greenblatt) % of 3.60% is 179.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Earnings Yield (Joel Greenblatt) % mean?
A high Earnings Yield (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's earnings yield equals the ratio of earnings before interest and taxes to enterprise value. View historical data on Abou Family Residence and its competitors. For the Medical Devices & Instruments industry, the median Earnings Yield (Joel Greenblatt) % is 1.29 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Abou Family Residence's current Earnings Yield (Joel Greenblatt) % is 3.60%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Abou Family Residence stock overvalued right now?
Abou Family Residence (XTAE:ABOU) has a current Earnings Yield (Joel Greenblatt) % of 3.60%. The current Earnings Yield (Joel Greenblatt) % is 3.60% and 179.1% above the Medical Devices & Instruments industry median of 1.29. Abou Family Residence's overall GF Score™ is 25/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Earnings Yield (Joel Greenblatt) % calculated?
Earnings Yield (Joel Greenblatt) % is calculated from a company's financial statements. For Abou Family Residence (XTAE:ABOU), the current Earnings Yield (Joel Greenblatt) % is 3.60% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Abou Family Residence Ltd formerly Envizion Medical Ltd is a medical device company. It is focused on improving patient outcomes across the continuum of care, encompassing the development of advanced, personalized navigation technology for feeding tubes, responding to the challenges of the ever changing healthcare environment, while continuously focusing on the customer.
25GF Score
Get the complete analysis for XTAE:ABOU
Earnings Yield (Joel Greenblatt) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XTAE:ABOU has been successfully added to your 
